These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29544572)
1. Effect of Metformin Alone Compared with Metformin Plus Simvastatin on Polycystic Ovarian Syndrome in Pakistani Women. Malik M; Tasnim N; Mahmud G J Coll Physicians Surg Pak; 2018 Mar; 28(3):184-187. PubMed ID: 29544572 [TBL] [Abstract][Full Text] [Related]
2. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ J Clin Endocrinol Metab; 2009 Dec; 94(12):4938-45. PubMed ID: 19890022 [TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. Banaszewska B; Pawelczyk L; Spaczynski RZ; Duleba AJ J Clin Endocrinol Metab; 2011 Nov; 96(11):3493-501. PubMed ID: 21865358 [TBL] [Abstract][Full Text] [Related]
4. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study. Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome. Seyam E; Hefzy E Gynecol Endocrinol; 2018 Dec; 34(12):1073-1080. PubMed ID: 30044162 [TBL] [Abstract][Full Text] [Related]
6. Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients. Ghazeeri G; Abbas HA; Skaff B; Harajly S; Awwad J J Endocrinol Invest; 2015 Jun; 38(6):643-51. PubMed ID: 25722221 [TBL] [Abstract][Full Text] [Related]
7. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study. Kazerooni T; Shojaei-Baghini A; Dehbashi S; Asadi N; Ghaffarpasand F; Kazerooni Y Fertil Steril; 2010 Nov; 94(6):2208-13. PubMed ID: 20079899 [TBL] [Abstract][Full Text] [Related]
8. Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies. Karakas SE; Banaszewska B; Spaczynski RZ; Pawelczyk L; Duleba A Gynecol Endocrinol; 2013 May; 29(5):483-7. PubMed ID: 23480783 [TBL] [Abstract][Full Text] [Related]
9. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Meng J; Zhu Y Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():19-24. PubMed ID: 33338947 [TBL] [Abstract][Full Text] [Related]
11. Metformin therapy in women with polycystic ovary syndrome. Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396 [TBL] [Abstract][Full Text] [Related]
12. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial. Chou KH; von Eye Corleta H; Capp E; Spritzer PM Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787 [TBL] [Abstract][Full Text] [Related]
13. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome. Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923 [TBL] [Abstract][Full Text] [Related]
14. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases]. Song J; Shen H; Li J; Huang Z; Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801 [TBL] [Abstract][Full Text] [Related]
16. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome. Kriplani A; Agarwal N J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709 [TBL] [Abstract][Full Text] [Related]
17. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
18. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome. Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242 [TBL] [Abstract][Full Text] [Related]
19. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome]. Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]